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Soil-transmitted helminths and Mycobacterium tuberculosis frequently coincide
geographically and it is hypothesized that gastrointestinal helminth infection may
exacerbate tuberculosis (TB) disease by suppression of Th1 and Th17 responses.
However, few studies have focused on latent TB infection (LTBI), which predominates
globally. We performed a large observational study of healthy adults migrating from Nepal
to the UK (n = 645). Individuals were screened for LTBI and gastrointestinal parasite
infections. A significant negative association between hookworm and LTBI-positivity
was seen (OR = 0.221; p = 0.039). Hookworm infection treatment did not affect LTBI
conversions. Blood from individuals with hookworm had a significantly greater ability to
control virulent mycobacterial growth in vitro than from those without, which was lost
following hookworm treatment. There was a significant negative relationship between
mycobacterial growth and eosinophil counts. Eosinophil-associated differential gene
expression characterized the whole blood transcriptome of hookworm infection and
correlatedwith improvedmycobacterial control. These data provide a potential alternative
explanation for the reduced prevalence of LTBI among individuals with hookworm
infection, and possibly an anti-mycobacterial role for helminth-induced eosinophils.
Keywords: tuberculosis, latent tuberculosis, LTBI, hookworm, eosinophil, growth inhibition
INTRODUCTION
Tuberculosis (TB) continues to be a major global health challenge despite reductions in prevalence
andmortality in the last 25 years. In addition to the significantmorbidity andmortality attributed to
TB disease, recent estimates suggest that one quarter of the world’s population is latently infected
with Mycobacterium tuberculosis (M.tb) (1, 2). On a similar scale, it has been estimated that up
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to one third of the global population is infected with intestinal
helminths (3–6). Soil-transmitted helminths andM.tb frequently
coincide geographically and between 20 and 35% of people with
TB disease are thought to be co-infected with helminths in high
burden regions, particularly in resource-poor settings (7).
Despite the significant spatial overlap and the apparent
prevalence of TB disease and helminth co-infection, there
is limited understanding of the relationship between these
pathogens. Helminths are commonly thought to modify the
host immune response through modulation of the Th1-Th2
immune axis and the induction of molecules such as IL-10 and
TGF-β, associated with a regulatory phenotype. Control of M.tb
infection requires pro-inflammatory Th1 and Th17 responses,
whilst helminth infection induces strong Th2 anti-inflammatory
responses, which may suppress Th1 profiles (8–10). As a result
it has been suggested that in individuals with M.tb infection,
helminth-induced immunomodulation promotes progression to
active TB disease, exacerbates TB pathology, and attenuates the
efficacy of anti-TB therapy and BCG vaccination (11–14).
However, data from human and animal studies have failed
to support the hypothesis that helminth infection has a negative
impact on either TB disease or cellular immune responses to a
candidate TB vaccine (15–22). In addition, despite the significant
burden of co-infection, there are few studies investigating the
association between helminths and latent TB infection (LTBI), or
the impact of helminths on the acquisition ofM.tb.
Furthermore, a small body of work suggests that helminth
infections may influence interpretation of interferon-gamma
(IFN-γ) release assays (IGRAs) used to diagnose LTBI, which rely
on Th1-mediated immune responses (23–26). Such an influence
may be skewing our understanding of the prevalence of M.tb
infection and warrants further investigation.
Our objective was to perform a longitudinal cohort study
investigating the relationship between LTBI and helminths in a
large, homogenous and well-controlled population of migrants
from an endemic region relocating to a low burden setting.
We hypothesized that the presence of helminths would have a
negative impact on host functional immune responses to M.tb.
However, we observed that asymptomatic hookworm infection
was associated with reduced risk of M.tb infection. Further
investigation of this relationship using an in vitro mycobacterial
growth assay and whole blood transcriptomics showed that
the presence of hookworm infection enhanced mycobacterial
growth inhibition and was associated with an eosinophil-related
transcriptomic signature. Our findings suggest that hookworm
infectionmay influence the outcome toM.tb but this may depend
upon the clinical status of theM.tb infection.
MATERIALS AND METHODS
Study Population and Experimental Design
This was a prospective, longitudinal cohort study of male
adult (≥18 years) military recruits who had recently arrived
in the UK from Nepal. The Nepalese vaccination policy for
TB is to immunize once at birth with BCG and the latest
estimates of TB incidence in Nepal are 154 (136–174) per 100,000
population (27). Participants were recruited between 2012 and
2015 and routine entry screening data were collected, including
full blood count, stool analyses for gastrointestinal parasites
(GIP), and serology for Strongyloides stercoralis infection. LTBI
status was determined by IGRA testing using the T-SPOT.TB
enzyme-linked immunospot (ELISPOT) assay (performed by
Oxford Immunotec, Abingdon, United Kingdom). IGRA testing
was repeated 3–6 months after the completion of treatment
for GIP to assess its impact on IGRA conversion rates. In
addition, an M.tb-specific ELISA, a functional mycobacterial
growth inhibition assay (MGIA) and whole blood transcriptomic
analysis were performed on peripheral blood samples from a
subgroup of participants with hookworm infection and matched
healthy controls. In accordance with current military and UK
migrant screening policy, HIV status was not determined.
The estimated prevalence of HIV infection among adults
aged 15–49 years in Nepal is 0.2% (27). All participants
provided written informed consent and ethical approval was
granted by the Ministry of Defence Research Ethics Committee
(MODREC 237/PPE/11). The study schedule is shown in
Figure 1.
Stool Analysis
Three separate fecal samples were received from each participant
at weekly intervals. Fresh fecal samples were processed as
follows: 1–2 g of feces was added to 10ml of formalin
water, mixed well by vortexing and left to stand for up to
3min. Fecal concentration was performed using a modification
to Ritchie’s formol-ether method with Evergreen R© fecal
parasite concentrators (28). Following concentration, two 22
× 22mm coverslips of sample were prepared and examined
by light microscopy for the presence of ova, cysts, or larvae.
Two experienced parasitology microscopists performed slide
examinations independently (scanned using x100 magnification,
with abnormalities scrutinized at x400). In addition, a fecal-
charcoal culture was established for each sample using standard
techniques (29). Following incubation for 6 days at 26◦C,
samples were examined for S. stercoralis or hookworm L3 larvae.
Slides were also prepared from the formol-ether deposit and
stained using the modified Ziehl Neilsen technique for the
presence of cryptosporidium or other coccidian oocysts (30).
Each slide contained two separate smears of fecal material and
two different experienced microscopists examined one smear
each. The presence or absence of parasitic infection was recorded.
The presence of Entamoeba cysts was excluded from analyses
because distinction between pathogenic (E. histolytica) and non-
pathogenic (E. dispar and E. moshkovskii) species is not possible
by microscopy due to morphological similarities.
Strongyloides stercoralis Serology
A sample of clotted blood was collected from each participant
and following centrifugation, serum was aliquoted and stored
at −20◦C. Samples were thawed and total IgG antibodies
to S. stercoralis were detected by ELISA using standard
protocols (31). Samples were tested in duplicate at a screening
dilution of 1:100 with a diagnostic threshold optical density
(OD) of ≥0.20.
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FIGURE 1 | Study schedule.
Mycobacterial Culture and Titrations
M.tb H37Rv was obtained from BEI Resources (VA, USA).
Frozen 1ml aliquots of strain stocks were thawed and grown
in 100ml Middlebrook 7H9 media with 10% OADC to mid-
log phase then divided into 1ml aliquots and stored at −80◦C
until required. Mycobacterial stocks were titrated by serial
dilution in supplemented 7H9 media and cultured in BACTEC
MGIT tubes supplemented with PANTA antibiotics and OADC
enrichment broth (Becton Dickinson, United Kingdom), as
previously described (32). In addition, the number of colony
forming units (cfu) for each dilution was determined by solid
culture on 7H10 agar plates. A standard curve of time-to-
positivity (TTP) against cfu was derived and linear regression
analysis generated an equation to convert experimental TTP to
cfu.
MGIT Mycobacterial Growth Inhibition
Assay
The whole blood direct MGIA was performed as previously
described (33). Duplicate tubes containing 300 µl of whole blood
were incubated with 300 µl of RPMI (containing 10% pooled
human serum, 2mM L-glutamine and 25mM HEPES; Sigma,
UK) inoculated with ∼150 cfu M.tb on a 360◦ rotator at 37◦C
for 96 h (volume of the mycobacterial stock was calculated to
give a TTP of 6.5 days, previously determined to give optimal
differential responses). Cells were then lysed with sterile water,
the mycobacteria resuspended in 7H9 media and transferred to a
BACTECMGIT tube supplemented with PANTA antibiotics and
OADC enrichment broth (Becton Dickinson, UK). Tubes were
placed in the BACTEC 960 machine and incubated at 37◦C until
the detection of positivity by fluorescence (TTP). In addition, on
day 0, duplicate viability control tubes were set up by directly
inoculating supplemented BACTEC MGIT tubes with the same
volume of mycobacteria as the samples.
Peripheral blood mononuclear cells (PBMC) were separated
from fresh heparinized whole blood by density gradient
centrifugation, cryopreserved and thawed using standard
techniques (34). The PBMC direct MGIA was as above but used
3 × 106 cryopreserved PBMC in 300 µl of RPMI-MGIT media
per culture, inoculated with ∼10 cfu M.tb (estimated TTP of 8.5
days) and then incubated in 48-well tissue culture plates at 37◦C
for 96 h (34). Mean TTP for duplicates was converted to a cfu
count (as described above) and net growth ratio was calculated
as Log10(sample cfu/control cfu). A smaller net growth value
indicates less bacillary replication and therefore represents
greater mycobacterial control.
Anti-M.tb IgG1 Enzyme-Linked
Immunosorbent Assays
Microtiter plates were coated overnight at room temperature
with a 1:1 mix of ESAT-6/CFP-10 (10µg/ml each) prepared from
M.tbH37Rv (BEI Resources). Native human IgG1 (2µg/ml; AbD
Serotec, UK) and PBS were included as positive and negative
controls (respectively). After washing with PBS containing 0.05%
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Tween 20 (PBS/T) and blocking with casein, serum samples were
tested in duplicate at 1:10 (diluted in casein). Casein was used for
control wells. After incubation at room temperature, biotinylated
secondary antibody (anti-IgG1; Life Technologies) at 1:1,000
dilution was added, followed by washing and the addition of
Extravidin-ALP (1:5,000; Sigma Aldrich). pNPP substrate (Sigma
Aldrich) was added and plates were read at 405 nm every 10min
using an ELx800 Microplate Reader with Gen5 software until
the IgG1 isotype control reached an OD of 0.6 (previously
determined from the gradient of a standard curve of native
human IgG1 ranging from 0.1 to 100µg/ml to avoid saturation).
The mean OD of negative controls was subtracted from the mean
OD of samples and readings with an OD > negative control plus
three standard deviations (SD) were considered positive.
Gene Expression Microarray
Transcriptomics
Peripheral blood was collected in PAXgene© tubes and stored at
−80◦C until required for whole blood transcriptomic studies as
previously described (33). Samples were subsequently thawed at
room temperature for 2 h, total intracellular RNA was extracted
using the Blood RNA Kit (Qiagen) and the purity and quantity
of RNA was assessed prior to storage at −20◦C. Globin mRNA
was depleted using the GLOBINclear Kit (Ambion), amplified
and biotin-labeled using the TotalPrep RNA Amplification Kit
(Illumina). RNA was purified and the quality assessed using
an Agilent bioanalyser. Biotinylated cRNA was hybridized to
Illumina HumanHT-12 (v4.0) expression beadchips according
to the manufacturer’s instructions. Beadchips were scanned with
an Illumina iScan bead array reader confocal scanner and data
extracted using GenomeStudio software.
Microarray Analysis
Raw, probe level summary values as exported from Illumina
GenomeStudio 2011 of Illumina HumanHT-12 (v4.0)
microarrays were imported into R using beadarray (35).
Probes were background corrected followed by quantile
normalization using the neqc command (36). The analysis was
restricted to probes with a detection p < 0.05 in at least 10%
of the samples and probes matching to GENCODE version 26
with at most 2 mismatches. A linear model was fitted using
limma to determine differential expression including parameters
for sample collection batch effects, as well as unobserved batch
effects, by the inclusion of the first three surrogate variables as
provided by the R package sva (37, 38). Array quality weights
were incorporated in order to account for between array quality
differences (37, 39). To account for between-patient correlation,
the duplicateCorrelation command from the limma package
was used. All p-values were corrected for multiple hypothesis
testing using the Benjamini-Hochberg procedure (40). The
transcriptomic dataset has been deposited in NCBI’s Gene
Expression Omnibus (GEO) database and is accessible through
accession number GSE122737.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
Software Version 6.0 (GraphPad, La Jolla, CA, United States)
and SPSS Statistics Version 22.0 (IBM, United States). Specific
statistical tests used are indicated in the results. For unsupervised
clustering, one minus the Pearson correlation coefficient was
used as dissimilarity metric to cluster samples, and complete
linkage was used as the agglomeration rule.
RESULTS
Hookworm Infection and Positive IGRA
Responses Are Negatively Correlated
A total of 649 individuals participated in the study, of whom
645 were included in the final analyses (Figure 1). Exclusions
were due to missing IGRA and/or stool results (n = 3) and a
diagnosis of probable active TB during screening (n = 1, smear-
negative pulmonary disease). All participants weremale and from
Nepal with a median age of 19.3 years (IQR 18.7–20.0 years).
LTBI was diagnosed by IGRA positivity in 102/645 (15.8%)
participants. The only difference in hematological parameters
between LTBI-positive and -negative groups was significantly
elevated eosinophil counts among LTBI-negative individuals
(Table 1).
GIP infections were identified in 140/645 (21.7%) participants,
among whom single, dual and triple infections numbered 115,
21, and 4 (respectively). Giardia lamblia was the most commonly
identified parasite (54/169, 32.0% of infections), followed by
hookworm (47/169, 27.8%) (Table 2). Quantification of GIP
infection was not formally recorded, but generally only low
burdens of infection were noted. There was no difference in GIP
infection status stratified by LTBI status, except for a significant
negative association between the presence of hookworm infection
and a positive IGRA (OR = 0.221; 95%CI 0.05–0.93; p = 0.039)
(Table 2). Further experiments were performed to assess whether
TABLE 1 | Age, IGRA and hematological characteristics of the population by LTBI
status.
Characteristic LTBI +
Median [IQR]
LTBI −
Median [IQR]
P-value*
n = 645 n = 102 n = 543
Age (years) 19.2 [18.6–19.9] 19.3 [18.7–20.0] 0.835
ESAT-6 SFU/well 10 [4.0–25.3] 0 [0.0–1.0] <0.0001
CFP-10 SFU/well 18 [9.8–36.3] 0 [0.0–1.0] <0.0001
n = 414 n = 65 n = 349
Total leucocytes (x109/L) 7.8 [6.6–9.6] 8 [6.7–9.4] 0.585
Neutrophils (x109/L) 4.8 [3.6–6.1] 4.7 [3.7–6.1] 0.920
Lymphocytes (x109/L) 1.9 [1.6–2.4] 2.1 [1.8–2.4] 0.092
Monocytes (x109/L) 0.4 [0.4–0.5] 0.4 [0.4–0.6] 0.743
Eosinophils (x109/L) 0.2 [0.1–0.4] 0.2 [0.2–0.4] 0.002
Basophils (x109/L) 0.0 [0.0–0.1] 0.1 [0.0–0.1] 0.687
Hemoglobin (g/L) 150 [143–158] 152 [147–158] 0.291
Mean cell volume (fL) 90.0 [87.5–93.6] 90.1 [87.8–92.4] 0.323
Platelets (x109/L) 236 [209–271] 250 [217–284] 0.118
*Mann-whitney U-test; significant differences highlighted in bold.
LTBI, latent TB infection.
IQR, interquartile range.
SFU, spot forming unit.
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TABLE 2 | Prevalence of GI parasite infection and association with IGRA positivity.
Helminth/protozoan species
n = 169
n LTBI +
n = 102
no. (%)
LTBI −
n = 543
no. (%)
P-valuea Univariate OR (95%CI) P-value
Ascaris lumbricoidesb 2 1 (1.0) 1 (0.2) – – –
Hookworm species 47 2 (2.0) 45 (8.3) 0.021 0.221 (0.05–0.93) 0.039
Hymenolepis nanab 6 3 (3.0) 3 (0.6) – – –
Strongyloides stercoralis 39 4 (4.0) 35 (6.4) 0.495 0.592 (0.21–1.71) 0.332
Trichuris trichiura 21 2 (2.0) 19 (3.5) 0.555 0.552 (0.13–2.41) 0.428
Giardia lamblia 54 7 (6.9) 47 (8.7) 0.697 0.778 (0.34–1.77) 0.550
Any helminth/protozoan 169 19 (18.6) 150 (27.6) 0.066 0.6 (0.35–1.02) 0.06
aFisher’s two-tailed LTBI+ vs. LTBI-; significant differences highlighted in bold.
bStatistical analyses were not performed where total parasite infection number was <10.
LTBI, latent TB infection; OR,odd’s ratio; CI, confidence interval.
this finding could be due to false-negative IGRA results in this
group.
Treatment of Hookworm Infection Does
Not Promote IGRA Conversion
If hookworms have a modulatory anti-Th1 effect then it could
be expected that IGRA-positivity would increase after treatment
of infection. To examine this we assessed IGRA conversion to
positivity in a subgroup of individuals with a negative IGRA
at baseline (n = 212). Among this group, 110 volunteers did
not have any evidence of GIP infection, while ≥1 GIP was
identified in 102 individuals (including 38 with hookworm).
IGRA testing performed 3–6 months after either no intervention
(for individuals without GIP infection, termed controls) or
completion of GIP treatment showed six conversions to positivity
in those without a GIP (5.5%), and five conversions in the
group with any GIP (4.9%) (Figure 2). There was no significant
difference in the rates of IGRA conversion between the groups (p
= 1.0, two-tailed Fisher’s exact test). Therefore, in our cohort the
treatment of GIPs did not significantly alter IGRA conversions or
change the number of LTBI diagnoses above the background rate.
M.tb-Specific Antibody Responses Are
Significantly Higher in Individuals With LTBI
Than in Those With Hookworm Infection
We have previously seen that IgG1 responses to certain M.tb-
specific antigens discriminate between individuals with LTBI and
uninfected controls (41). To identify whether humoral responses
to M.tb also differed between the helminth-infected and non-
infected groups, we measured IgG1 levels against ESAT-6 and
CFP-10, two antigens present in M.tb but not BCG, in serum
from uninfected healthy controls (n = 28), and individuals with
either LTBI (n = 47) or hookworm infection (n = 13). Antibody
responses were significantly higher in the LTBI group (median
OD405 = 0.085) compared to the control and hookworm groups
(median OD405 = 0.052 and 0.032, respectively; Figure 3),
consistent with the results of IGRA testing.
Individuals With Hookworm Infection Have
Improved in vitro Mycobacterial Control
Which Is Reversed After Helminth
Treatment
The functional ability of an individual to control growth of
virulent mycobacteria was assessed in the direct MGIA using
samples before and after successful treatment for hookworm
infection. Whole blood samples were available from 9 uninfected
controls and matched pre- and post-treatment samples from
13 individuals with hookworm infection. Growth of M.tb was
significantly lower in pre-treatment hookworm whole blood
compared to controls (mean net growth: 0.74 vs. 0.88 log10 cfu,
p = 0.0019; Figure 4A). Mycobacterial net growth increased
significantly after treatment for hookworm infection (mean net
growth = 0.85 log10 cfu, p = 0.0086), to levels comparable to the
controls. Whole blood contains several cellular constituents that
may have anti-mycobacterial functions, therefore we assessed
which elements correlated with the mycobacterial growth
rate using all samples and each time point (n = 34). The
only significant correlation seen was a negative relationship
between net growth and eosinophil counts (rho = −0.42, p
= 0.013; Figure 4B). Finally, we repeated the MGIA using
cryopreserved PBMC (lacking eosinophils). Matched pre- and
post-treatment PBMC samples were available from 12 individuals
with hookworm infection and baseline samples from 9 controls.
A pattern similar to the whole blood experiments was seen, with
reduced mycobacterial growth in individuals before treatment
for hookworm, which increased following treatment (mean net
growth: 0.32 vs. 0.48 log10 cfu, p= 0.0027; Figure 4C). Therefore,
the in vitro ability to control growth of M.tb was improved
among individuals with hookworm infection and this control was
associated with higher eosinophil counts in whole blood.
Eosinophil-Associated Transcriptomic
Profiles in Whole Blood Correlate With
Improved Mycobacterial Control
To investigate the association between increased eosinophil
counts and improved M.tb control in the blood of hookworm
infected individuals, we performed an unbiased assessment
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FIGURE 2 | Treatment of hookworm infection does not promote IGRA conversion to positivity. Longitudinal IGRA responses were assessed among individuals with a
negative IGRA at baseline (n = 212). IGRA testing was repeated after either no intervention (no GIP infection, n = 110, A,B) or after GIP treatment (any GIP infection, n
= 102, C,D). While there were significant increases in some T cell responses to M.tb-specific antigens, there was no significant difference in the conversion rate to
IGRA positivity between the groups (E). GIP, gastrointestinal parasite; SFC, spot forming cells; T, time point; Rx, treatment for GIP; gray dashed line, threshold for a
positive IGRA; ns, non-significant; *p < 0.05.
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FIGURE 3 | IgG1 responses to M.tb-specific antigens are significantly different
between individuals with LTBI and those with hookworm infection.
Antigen-specific IgG1 responses to ESAT-6/CFP-10 in pre-treatment serum
samples from uninfected healthy controls (n = 28), and individuals with either
LTBI (n = 47) or hookworm infection (n = 13) were determined by ELISA.
Optical densities (ODs) are reported following subtraction of the background.
Points represent the mean of duplicates and bars are the median values with
the interquartile range. After normality testing a Kruskal-Wallis test with Dunn’s
correction for multiple comparisons was performed. ns, non-significant; *p <
0.05. LTBI, latent TB infection; HW, hookworm.
of the impact of hookworm infection on whole blood
by transcriptomics. Transcriptomics was performed on
unstimulated whole blood samples from uninfected controls
(n = 9) and individuals with hookworm infection (matched
pre- and post-treatment, n = 11). We identified 112 significant
probes, mapping to 104 genes, specific to individuals with
hookworm infection before treatment (Figure 5A). Adjustment
for eosinophil counts resulted in the complete loss of this
hookworm-specific signature, suggesting that eosinophils
are the primary contributor to the transcriptomic profile
(Figure 5B). This was supported by the strong correlation of the
transcriptomic changes to eosinophil counts and the changes
following treatment of hookworm infection (Figure 6A). Further
analysis of the signature showed it to be consistent with previous
published studies of eosinophil-associated gene expression
(Figure 6B). Finally, we performed unsupervised clustering
analysis of the hookworm-specific transcriptional signature
(Figure 7). Clustering of the expression data by columns
separated the samples into two broad clusters. The black cluster
which contained all 11 pre-treatment hookworm samples,
showed a distinct cluster as compared to the red cluster which
contained 19 of the 20 control and hookworm post-treatment
samples. Mycobacterial growth control as determined by whole
blood in vitro MGIA was significantly improved (p < 0.003) in
the black pre-treatment cluster as compared to the red cluster.
DISCUSSION
Despite the huge global burden of LTBI and intestinal parasites,
and their geographical overlap, there are few robust studies
examining the relationship between them. We have performed
a prospective study in a large well-defined cohort of adults
and show, for the first time, that hookworm infection is
negatively associated with LTBI and also with improved control
of mycobacterial growth in vitro.
An important element of our findings, which challenge
current dogma, is consideration of how intestinal helminth
infections may affect diagnostic tests for LTBI. The T cell-
based IGRAs rely on M.tb-specific antigens to stimulate effector
T cells, eliciting the secretion of IFN-γ as an indicator of
infection. The helminth-induced polarization of the immune axis
postulated by several investigators may induce a Th2 response
and therefore result in false-negative IGRA results. To date,
studies have only shown an association between indeterminate
IGRA results and helminths in pediatric populations using
ELISA-based Quantiferon (QFT) IGRA tests. Indeterminate QFT
results mainly occur due to failure of the positive mitogen
control and are significantly associated with younger age, iron
deficiency, and malnutrition (23–26). Malnourished individuals
have reduced numbers of T cells and their function is impaired,
resulting in reduced IFN-γ production in both human and
animal studies (43–45). Therefore, indeterminate IGRAs could
represent the direct effects of malnutrition, which may be
independent of helminth infection. These confounders were not a
feature in our population of healthy, asymptomatic young adults.
We sought to investigate this further and present evidence
suggesting that helminth-induced false negative IGRA results
did not occur in our cohort. Firstly, there was no significant
difference in IGRA conversions to positivity among individuals
following successful treatment for hookworm compared with
the background rate in uninfected controls. If the IGRA results
were falsely negative due to a hookworm-induced Th2 shift, it
is plausible that restoration of unencumbered Th1 responses
after treatment would result in excess IGRA conversions. We
suggest that the absence of such phenomena during longitudinal
assessment is further evidence that IGRA testing was not
confounded by hookworm infection. Moreover, in a mouse
model of helminth and Salmonella infection, helminths did
not modulate Th1 responses (46). Secondly, humoral responses
may have a role in serodiagnostics for TB and therefore we
assessed antibody responses (47–49). We have previously shown
a strong negative association between IgG1 responses to the
RD1-restricted protein antigens ESAT-6/CFP-10 and in vitro
mycobacterial growth among individuals with LTBI and active
TB disease, reflecting bacillary burden and therefore disease
status (41). In this study, we found comparably low antibody
responses to ESAT-6/CFP-10 among uninfected controls and
individuals with hookworm that, in the context of a negative
IGRA, we contend reflects the absence of LTBI.
Finally, we have shown that prior to treatment for hookworm,
infected individuals demonstrate improved growth control of
virulent M.tb in both a whole blood and PBMC MGIA, and this
ability is lost after successful treatment. Previous studies of the
relationship between TB and helminth infections have measured
individual immune parameters, such as cytokine secretion by
antigen-specific T cells. However, given the complexity of these
pathogens such an approach may be over simplistic. In contrast,
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FIGURE 4 | In vitro differential mycobacterial control is improved among individuals with hookworm infection in whole blood and PBMC and is lost after helminth
treatment. Whole blood and PBMC MGIT using M.tb H37Rv was performed to assess mycobacterial control. Whole blood samples were available from uninfected
controls (n = 9) and matched pre- and post-treatment samples from hookworm infected individuals (n = 13) (A). The relationship between mycobacterial net growth
and hematology parameters was investigated. After testing for normality, Spearman’s correlations were calculated between hematology data and all whole blood M.tb
H37Rv MGIT results (n = 34) and showed a significant negative correlation growth and eosinophil count (B). MGIA was also performed using cryopreserved PBMC
with matched pre- and post-treatment PBMC samples from individuals with hookworm infection (n = 12) and controls (n = 9) (C). For MGIT data, points represent the
mean of duplicates; bars represent mean values with SD. A one-way multiple comparison ANOVA with Tukey’s post-test correction was performed between the
groups. HW, hookworm; Rx, treatment; ns, non-significant; **p < 0.005.
in vitro MGIAs are functional assays that provide a summative
assessment of a range of immune mechanisms and their complex
interactions within a biological sample (50). In the absence of
defined mechanisms, this assay provides an unbiased assessment
of mycobacterial control as a measure of anti-mycobacterial
immunity. The novel findings we have described using this assay
are consistent with our immuno-epidemiological observations.
It was not possible to include an LTBI-positive, hookworm-
negative control group in either the whole blood or PBMC-
based MGIA in this study. However, we have recently described
such a population using an M.tb whole blood MGIA and as
we use standard controls and report the functional output as a
growth ratio, these data are comparable between studies (41).
In that study the growth control of H37Rv among individuals
with evidence of LTBI (IGRA-positive) was enhanced in relation
to uninfected healthy controls, which we suggested was due to
increased immune activation in response to bacillary burden.
The M.tb growth rate in pre-treatment hookworm infected
individuals in this study was less than that observed previously
among those who were LTBI-positive (hookworm-negative).
While speculative, we again propose that this finding may arise
from differential immune activation and possibly suggests a
contribution from innate cells not identified in previous cohorts
(e.g. eosinophils).
The validity of our findings is supported by the reversal
of improved control following treatment for hookworm. While
assessment of the mechanism was beyond the scope of this
study, we hypothesize that eosinophils may contribute to this
control for several reasons. Firstly, the only difference in
hematological parameters between groups based on IGRA status
was increased eosinophil counts among those negative for
LTBI. Secondly, the transcriptomic profile of whole blood from
hookworm infected individuals was dominated by an eosinophil-
associated signature that did not persist after normalization
of eosinophil counts (either after hookworm treatment or by
correction during microarray analysis). Some of the significantly
expressed genes we identified that have been associated with
eosinophils included PRSS33, CCL23, IL5RA, and SIGLEC8.
PRSS33 (protease serine 33) is a single hydrophobic-domain
transmembrane protein constitutively expressed in human
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FIGURE 5 | A hookworm-specific transcriptional signature comprising 112
significant probes was detected in infected compared to treated and
uninfected individuals and adjustment for eosinophil count leads to loss of the
hookworm-specific signature. (A). Volcano plot showing magnitude and
significance of differential expression between hookworm infected volunteers
before and after treatment. Infected volunteers post-treatment were analyzed
in combination with a hookworm naïve control group to increase power. Gene
names of the top 50 probes with an FDR below 20% are shown above the
dashed line. FC, fold-change; HW, hookworm; pre and post refer to treatment.
(B). Volcano plot showing the fold changes between hookworm infected
volunteers before and after treatment. The linear model contained eosinophil
counts as an additive term to adjust for differences in eosinophils. No probe
reached significance at 20% FDR. FDR, false discovery rate.
eosinophils. Cell surface expression of PRSS33 is associated
with fibroblast extracellular matrix protein synthesis in activated
eosinophils (51). CCL23, a novel C-C chemokine, is a CCR1
agonist with chemotactic activity on monocytes, dendritic
cells, and resting T lymphocytes, together with roles in the
potentiation of VEGF-induced proliferation and migration of
human endothelial cells. Eosinophils have been shown to produce
and release CCL23 following stimulation with GM-CSF or IL5
(52). The alpha subunit receptor for IL5 (IL5RA), which is IL5-
specific, was another highly expressed gene we identified that
correlated significantly with eosinophils. IL5 is the principal
cytokine involved in the maturation, proliferation, and activation
FIGURE 6 | Hookworm-specific transcriptional signature is highly correlated to
transcriptomic correlates of eosinophil count and is consistent with previously
published signatures. (A). Scatterplot of log2 fold changes of hookworm
infected vs. post treatment and control samples. A regression line was added
to highlight the correlation of the two contrasts and gene names of the top 100
differentially expressed probes were added. Point color indicates the 302 and
112 significantly differentially expressed probes below 20% FDR in hookworm
infected and eosinophil counts, respectively. Seventy four probes are
significantly differentially expressed in both contrasts. (B). Of the top 50 genes
described to be significantly associated with eosinophils based on whole blood
gene expression in a recent publication (42), 40 were detected in our study
and the gene names of all probes representing these genes are indicated.
of eosinophils (53). Finally, SIGLEC8 (sialic acid binding Ig-
like lectin 8) is a single pass transmembrane inhibitory receptor
predominantly expressed on the surface of human eosinophils
which, following the binding of specific glycans, induces
eosinophil apoptosis (54). Clinically, SIGLEC8 may play a role in
preventing chronic lung inflammation in asthma by inducing cell
death of activated eosinophils, supported by the observation that
polymorphisms have been associated with asthma susceptibility
in humans (55, 56). Collectively, the dominant differential
expression of these and other genes, and their correlation with
eosinophil counts, provide evidence for an eosinophil-specific
transcriptomic profile which is also consistent with the findings
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FIGURE 7 | Unsupervised clustering of the hookworm-specific transcriptional signature reveals correlation to mycobacterial growth inhibition. Normalized expression
values of 112 probes mapping to 104 genes were mean centered and scaled and columns were clustered using hierarchical clustering as described in the Materials
and Methods. The two largest clusters of patients were colored in red and black and the two most distinct clusters of probes were separated into cluster 1 and cluster
2 by k-means clustering. MGIA control was significantly improved (p < 0.003) in the black cluster compared to the red cluster. A Welch Two Sample t-test was
performed between groups. Rx, treatment.
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of other investigators (42, 57). Thirdly, the number of eosinophils
in whole blood was the only cellular constituent to correlate
with mycobacterial growth in vitro. Interestingly, a recent study
has also shown a negative correlation between mycobacterial
growth rate and eosinophil count in blood from African buffalo
(Syncerus caffer) (58). Eosinophils have an important role in
innate immune responses, particularly against helminths, and
while typically present in low numbers, may make a significant
contribution to the proportion of blood leucocytes when elevated
(indeed, in our hookworm infected cohort eosinophils accounted
for up to 14% of total leucocytes and 23% of polymorphonuclear
cells) (59). We suggest that hookworm-induced eosinophilia
may have a role in defense against M.tb, supported by studies
from other investigators showing that these cells are activated
by mycobacteria, accumulate at sites of mycobacterial infection
and have anti-mycobacterial activity through the secretion of
cytotoxic proteins (60–63).
However, this study was not designed to formally assess
the possible direct and/or indirect mechanisms of eosinophil
activity against M.tb. For example, apart from the direct anti-
mycobacterial action of eosinophils to control M.tb growth, the
indirect action of Th2-mediated control of lung tissue damage
may modulate susceptibility to M.tb infection. We acknowledge
that our findings are of association rather than causation and
accept that quantitative differences in eosinophil counts may
not result in qualitative differences in eosinophil function;
further studies are required. In addition, we do not suggest
that eosinophils are the sole mediators of mycobacterial control,
as evidenced by the PBMC-based MGIA in which reduced
growth of M.tb in hookworm infected individuals was seen in
the absence of polymorphonuclear cells. Differential adaptive
immune responses are likely to be important and as the number
of PBMC has been standardized in this assay, it suggests that
anti-mycobacterial control is due to qualitative rather than
quantitative factors, consistent with other studies (64).
Furthermore, consideration of helminths with a pulmonary
migratory phase, such as hookworm, adds to the biological
plausibility of our findings. Studies show that even a transient
exposure to hookworm not only recruits innate cells to the lungs
(both eosinophils and alternatively activated macrophages), and
induces changes in T and B cells, but can also produce long-
lived alterations in the pulmonary immune environment that
may have a role in enhancing subsequent responses to respiratory
pathogens, includingM.tb (18, 65–67).
The strengths of our study are predominantly due to the
size and nature of the population, together with the study
setting. Participants were matched for age, sex, and ethnicity and
both helminth and M.tb exposure was controlled for as study
participants were confined to a military training facility in a non-
endemic setting. Assessment of GIP infection and LTBI status was
comprehensive. Limitations include a relatively small number of
hookworm infected individuals for subgroup analysis and that
our population was extremely fit and healthy with low burdens of
GIP infection. These individuals are unlikely to be representative
of typical migrants relocating to low endemic regions.
In summary, we have shown that in a healthy young
adult group of migrants arriving in the UK, asymptomatic
hookworm infection is negatively associated with the presence
of M.tb infection and with improved in vitro control of
mycobacteria, whichmay be partly attributable to number and/or
function of eosinophils. Further studies of the possible role of
eosinophils in this context are warranted to investigate this
further. Finally, these findings may have implications for mass
drug administration (MDA) programmes intended to reduce
or eliminate soil-transmitted helminths, including hookworm.
The benefits of such programmes in reducing malnutrition
and anemia and possible improvement in cognitive function
of children continue to be debated, particularly for hookworm
infections, which affect both children and adults in endemic
settings (6, 68, 69). The effect of MDA programmes on the
prevalence and severity of TB and the success of TB control
programmes has not, to our knowledge, been systematically
investigated.
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